Research Funding Opportunities

Post Funding Opportunity

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or …

Deadline: May 7, 2026

NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)

National Institutes of Health

NIMHD invites applications to support short-term exploratory or developmental research projects that have the potential to break new ground in the fields of minority health …

Deadline: May 7, 2026

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this NOFO is to announce support for meritorious research projects that address research questions relevant to human dental, oral, or craniofacial (DOC) …

Deadline: May 7, 2026

Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)

National Institutes of Health

The Office of Research Infrastructure Programs (ORIP) within the Division of Program Coordination, Planning, and Strategic Initiatives announces an opportunity to apply for small grant …

Deadline: May 7, 2026

Collaboration for Innovative Research on Aircraft Structure (CIRAS)

Air Force -- Research Lab

Collaboration for Innovative Research on Aircraft Structure (CIRAS) The Aerospace Vehicles Division (RQV), Aerospace Systems Directorate (RQ), Air Force Research Laboratory (AFRL), is soliciting research …

Deadline: May 11, 2026

NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)

National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages applications that propose to complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. …

Deadline: May 13, 2026

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)

National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health …

Deadline: May 18, 2026

Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)

National Institutes of Health

This funding opportunity announcement (FOA) encourages grant applications that support the activities of the National Primate Research Centers (NPRCs). Nonhuman primates (NHPs) are most closely …

Deadline: May 25, 2026

NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)

National Institutes of Health

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- …

Deadline: May 25, 2026

NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)

National Institutes of Health

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- …

Deadline: May 25, 2026

Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIAAA/NIDA R25 program …

Deadline: May 25, 2026

NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)

National Institutes of Health

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- …

Deadline: May 25, 2026

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

National Institutes of Health

This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic …

Deadline: June 2, 2026

NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)

National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage institutions to propose creative and innovative institutional research career development programs which will …

Deadline: June 9, 2026

Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this NOFO is to support the creation of standards and related efforts that will allow researchers to easily access data from personal …

Deadline: June 10, 2026

Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)

National Institutes of Health

The purpose of this NOFO is to support the NIGMS Human Genetic Cell Repository (HGCR). The repository will maintain the current collection of cell cultures …

Deadline: June 10, 2026

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

National Institutes of Health

The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of …

Deadline: June 22, 2026

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)

National Institutes of Health

The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of …

Deadline: June 22, 2026

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

National Institutes of Health

The purpose of this notice of funding opportunity (NOFO) is to support rigorous analytical validation of method(s) used for measuring biomarkers for neurological and neuromuscular …

Deadline: June 22, 2026

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

National Institutes of Health

(Reissue PAR-21-057) The purpose of this Program Announcement (PAR) is to enable analytical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the …

Deadline: June 25, 2026

Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)

National Institutes of Health

The purpose of the Native American Research Centers for Health (NARCH) Planning Grants program is to support federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal …

Deadline: July 8, 2026

AHRQ Mentored Career Enhancement Awards for Established Investigators in Patient-Centered Outcome Research (K18)

Agency for Health Care Research and Quality

The purpose of this Mentored Career Enhancement grant awards (K18) in Patient Centered Outcomes Research (PCOR) NOFO is to target established mid-career and senior investigators …

Deadline: July 12, 2026

Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an …

Deadline: July 14, 2026

NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS R25 program …

Deadline: July 14, 2026

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)

National Institutes of Health

This notice of funding opportunity (NOFO) encourages applications for investigator-initiated multi site clinical trials (e.g., efficacy, effectiveness, or pragmatic trials) to study the effects of …

Deadline: July 14, 2026

Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)

National Institutes of Health

This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an …

Deadline: July 14, 2026

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages cooperative agreement applications for investigator-initiated, multi-site, clinical trials (Phase III and beyond) to study the effects of natural …

Deadline: July 14, 2026

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages cooperative agreement applications for investigator-initiated, multi-site, clinical trials (Phase III and beyond) to study the effects of natural …

Deadline: July 15, 2026

Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)

Agency for Health Care Research and Quality

This NOFO invites applications that propose research projects that test promising digital healthcare interventions used at the point of care and aimed at improving the …

Deadline: July 31, 2026

Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional

National Institutes of Health

The National Human Genome Research Institute (NHGRI) seeks to broaden the types of knowledge, skills, expertise, experience, and perspectives brought to bear in research addressing …

Deadline: Aug. 2, 2026

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) …

Deadline: Aug. 6, 2026

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

National Institutes of Health

The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). …

Deadline: Aug. 25, 2026

Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

National Institutes of Health

The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). …

Deadline: Aug. 25, 2026

NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)

National Institutes of Health

(Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology …

Deadline: Sept. 5, 2026

NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)

National Institutes of Health

(Reissue of PAR-21-266) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation …

Deadline: Sept. 5, 2026

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

National Institutes of Health

This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived …

Deadline: Sept. 7, 2026

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

National Institutes of Health

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) …

Deadline: Sept. 7, 2026

Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

National Institutes of Health

This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived …

Deadline: Sept. 7, 2026

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the …

Deadline: Sept. 7, 2026

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

National Institutes of Health

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the …

Deadline: Sept. 7, 2026

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)

National Institutes of Health

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will …

Deadline: Sept. 7, 2026

Alcohol Health Services Research (R01 Clinical Trial Optional)

National Institutes of Health

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will …

Deadline: Sept. 7, 2026

NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed)

National Institutes of Health

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of …

Deadline: Sept. 7, 2026

Alcohol Health Services Research (R34 Clinical Trial Optional)

National Institutes of Health

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will …

Deadline: Sept. 7, 2026

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

National Institutes of Health

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This …

Deadline: Sept. 7, 2026

National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on …

Deadline: Sept. 7, 2026

Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

National Institutes of Health

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the …

Deadline: Sept. 7, 2026

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on …

Deadline: Sept. 7, 2026
385 - 432 of 624